Result of AGM

Hutchison China Meditech Limited
09 May 2008




                  Hutchison China MediTech Limited ('Chi-Med')

                                   (AIM: HCM)




                       Results of Annual General Meeting



London, Friday, 9 May 2008: Chi-Med today announces that all ordinary
resolutions and special resolution put to its Annual General Meeting ('AGM')
held on 9 May 2008 were duly passed.  The poll results of the resolutions were
as follows:


                                                                           Number of Votes (%)*
Ordinary Resolutions                                                  For        Against      Withheld


1      To consider and adopt the audited financial statements     41,885,390        0             0
       and the reports of the directors and independent auditor
       for the year ended 31 December 2007.                        (100.00%)     (0.00%)       (0.00%)

2(a)   To re-elect Mr Simon To as a director.                     41,735,389        0          150,000

                                                                   (99.64%)      (0.00%)       (0.36%)

2(b)   To re-elect Mr Christian Salbaing as a director.           41,114,739     770,651          0

                                                                   (98.16%)      (1.84%)       (0.00%)

2(c)   To re-elect Mr Michael Howell as a director.               41,885,390        0             0

                                                                   (100.00%)     (0.00%)       (0.00%)

3      To re-appoint PricewaterhouseCoopers as the auditor of     41,885,390        0             0
       the Company and authorise the board of directors to fix
       the auditor's remuneration.                                 (100.00%)     (0.00%)       (0.00%)

4(a)   Item 4(A) of the notice of the Meeting                     41,885,390        0             0

       (To grant a general mandate to the directors of the         (100.00%)     (0.00%)       (0.00%)
       Company to issue additional shares)

4(b)   Item 4(B) of the notice of the Meeting                     41,885,390        0             0

       (To grant a general mandate to the directors of the         (100.00%)     (0.00%)       (0.00%)
       Company to repurchase shares of the Company)

5      Item 5 of the notice of the Meeting                        41,885,390        0             0

       (To extend the general mandate to the directors of the      (100.00%)     (0.00%)       (0.00%)
       Company to issue additional shares)


Special Resolution


6      Item 6 of the notice of the Meeting                        41,885,390        0             0

       (To amend the Articles of Association of the Company)       (100.00%)     (0.00%)       (0.00%)





*All percentages rounded to 2 decimal places.



As at the date of the AGM, the number of issued shares of Chi-Med was
51,229,174, which was the total number of shares entitling the holders to attend
and vote on the ordinary resolutions and special resolution proposed at the AGM.






                                      Ends





Enquiries


Citigate Dewe Rogerson                           Telephone: [phone]

Anthony Carlisle                                 [phone]

David Dible                                      [phone]





About Chi-Med



Chi-Med is the holding company of a pharmaceutical and healthcare group focused
on traditional Chinese medicine ('TCM') based primarily in China and was
admitted to trading on the Alternative Investment Market of the London Stock
Exchange in May 2006.  Chi-Med operates three core business Divisions: 1) China
Healthcare - the manufacture, distribution and marketing of pharmaceuticals and
health supplements in China; 2) Drug R&D - the discovery and global development
of novel drug in the oncology and auto-immune therapeutic areas; and 3) Consumer
Products - global retailing and distribution consumer health and personal care
products derived from TCM and botanical ingredients.



Chi-Med is majority owned by Hutchison Whampoa Limited, an international company
listed on the Main Board of The Stock Exchange of Hong Kong Limited.


                      This information is provided by RNS
            The company news service from the London Stock Exchange